Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

Bitcoin Drops, Ethereum Plummets: Inside the Latest Crypto Swing With Tony Edward

Tony Edward breaks down recent Bitcoin and Ethereum drops, ETF outflows, and what investors should watch in the turbulent crypto market.

Death of the binge model? Netflix goes back to “slow drip” releases

Netflix has switched from the binge model to the "slow drip" release of its hot shows. Why? And what the heck?!

Box Office Goes Wild: Zootopia 2 Roars, Wicked Soars, and Christmas Is Set to Explode

Seth Schachner breaks down Zootopia 2’s record-smashing debut, holiday box office trends, early 2026 Oscar contenders, and what’s next for Netflix and WBD.

From Heritage to High Voltage: Scout Motors Revives Classic Trucks

Scout Motors is reviving iconic American trucks with electric power, blending classic design with modern EV innovation for a new generation.

Is a December Cut the Fed’s Holiday Surprise?

Truist's Mike Skordeles unpacks earnings trends, market correction, labor force dynamics, and what a possible December rate cut could mean for all of us.

From Runway to Wall Street: CEO Andrés Conesa on AeroMexico’s IPO

CEO Andrés Conesa talks AeroMexico’s NYSE debut and how the airline plans to navigate growth in the competitive aviation market.

Load More